Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × oprelvekin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Specimen Handling 204 Magnetic Resonance Spectroscopy 165 pembrolizumab 153 Carboplatin 122 Biopsy 111 Cisplatin 97 Gemcitabine 86 Cyclophosphamide 79 Paclitaxel 78 Bevacizumab 77 Nivolumab 66 Docetaxel 56 fludarabine 53 venetoclax 52 Radiotherapy 47 Pemetrexed 47 Oxaliplatin 47 atezolizumab 46 Fluorouracil 43 durvalumab 40 Dexamethasone 40 Rituximab 39 Leucovorin 39 Radiation 36 Cetuximab 35 130-nm albumin-bound paclitaxel 35 Taxes 34 Ipilimumab 34 Drug Therapy 34 Prednisone 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡